![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
Tagged: drug development
Merck has taken a step that many people have been expecting, and announced that they are no longer developing taranabant, their cannabinoid antagonist (or is it an inverse agonist?) I'd expressed grave doubts about the drug earlier this year, which turned out to be well-founded. That latter post included the line "I don't see how they can get this compound through the FDA", and now Merck seems … Continue Reading »